Results 151 to 160 of about 4,582,351 (335)
Reaction to long-term oral anticoagulant therapy. A comparison of prothrombin and partial thromboplastin tests. [PDF]
R. D. Eastham
openalex +1 more source
ABSTRACT Background Up to 50% of patients with ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD). Aims This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post ...
Roberto Scarsini+15 more
wiley +1 more source
ANTICOAGULANT TREATMENT IN PATIENTS WITH RENAL INSUFFICIENCY
BACKGROUND In the recent years, the number of patients treated with anticoagulant therapy isincreasing. Among them, there is also an increased number of patients with renal insufficiency.Due to changes in coagulation and fibrinolityc system activity ...
Gregor Tratar+7 more
doaj
Spinal Epidural Hematoma in Patients on Anticoagulant Therapy*
Richard E. Strain
openalex +2 more sources
Fibrinopeptide A (FPA) Levels in Venous Thrombosis and Pulmonary Embolism Before and During Anticoagulant Therapy [PDF]
I. Yudelman+3 more
openalex +1 more source
ABSTRACT Background Plug‐based vascular closure devices (Pb‐VCD) and suture‐based vascular closure devices (Sb‐VCD) are used for percutaneous vascular access site closure during transcatheter aortic valve replacement (TAVR). Until now, no clear superiority of either device was shown in studies comparing 18 F VCDs solely.
Tobias Lerchner+6 more
wiley +1 more source
ABSTRACT Background Cardiovascular therapeutic devices typically require systemic heparin due to underlying thrombotic risk. The Impella axial flow system further relies on internal perfusion with either a heparin‐containing or sodium bicarbonate purge solution during operation.
Kaitlyn R. Ammann+7 more
wiley +1 more source
Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy [PDF]
BC Furie+5 more
openalex +1 more source
ABSTRACT Background The use of procedural anticoagulation during primary percutaneous coronary intervention (PCI) is well established and has been shown to improve clinical outcomes in patients with ST‐segment elevation myocardial infarction (STEMI).
Vinícius Martins Rodrigues Oliveira+11 more
wiley +1 more source